FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Dr. Reddy's Laboratories Allergy Relief D Recall

Allergy Relief D, Fexofenadine HCL 60mg/Antihistamine, Pseudoephedrine HCL 120mg/Nasal…

Dr. Reddy's Laboratories, Inc. · Princeton, NJ

Risk level
Class III
Reported by FDA
Dec 7, 2022
Recall ID
D-0073-2023
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled Allergy Relief D starting Nov 21, 2022. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0073-2023 on Dec 7, 2022. Reason: Failed dissolution specifications. Status: Terminated.

Why it was recalled

Failed dissolution specifications

Product description

Allergy Relief D, Fexofenadine HCL 60mg/Antihistamine, Pseudoephedrine HCL 120mg/Nasal Decongestant, Extended-Release Tablets USP, packaged as (a) 20 count carton NDC 49032-273-20; (b) 30 count carton, NDC49032-273-30; Distributed by: Walmart Inc., Bentonville, AR 72716, Product of India

Lot numbers, UPCs & expiration codes

Lot# (a) AC2203133B, EXP 01/2024; (b) AC2203133A, EXP 01/2024.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0073-2023
Classification
Class III
Status
Terminated
Recall initiated
Nov 21, 2022
FDA report date
Dec 7, 2022
Quantity
25,176, 30-count; 22,968 20-count
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0073-2023, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
91190
Address
107 College Rd E
Code information
Lot# (a) AC2203133B, EXP 01/2024; (b) AC2203133A, EXP 01/2024.
Postal code
08540-6623
Report date
Dec 7, 2022
Product type
Drugs
Recall number
D-0073-2023
Classification
Class III
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product quantity
25,176, 30-count; 22,968 20-count
Termination date
Aug 28, 2024
Reason for recall
Failed dissolution specifications
Product description
Allergy Relief D, Fexofenadine HCL 60mg/Antihistamine, Pseudoephedrine HCL 120mg/Nasal Decongestant, Extended-Release Tablets USP, packaged as (a) 20 count carton NDC 49032-273-20; (b) 30 count carton, NDC49032-273-30; Distributed by: Walmart Inc., Bentonville, AR 72716, Product of India
Distribution pattern
Nationwide in the USA
Recall initiation date
Nov 21, 2022
Initial firm notification
Letter
Center classification date
Nov 30, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0073-2023, published Dec 7, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls